|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3212670 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15798264.6 |
| Date of filing the European patent application | 2015-10-28 | |
| (97) | Date of publication of the European application | 2017-09-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
| (46) | Date of publication of the claims translation | 2021-02-10 |
| (86) | Number | PCT/US2015/057781 |
| Date | 2015-10-28 |
| (87) | Number | WO 2016/069727 |
| Date | 2016-05-06 |
| (30) | Number | Date | Country code |
| 201462072035 P | 2014-10-29 | US | |
| 201562157368 P | 2015-05-05 | US | |
| 201562192025 P | 2015-07-13 | US |
| (72) |
WONG, Brian, US
HAMBLETON, Julie, US
SIKORSKI, Robert, US
MASTELLER, Emma, US
HESTIR, Kevin, US
BELLOVIN, David, US
LEWIS, Katherine E., US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
Five Prime Therapeutics, Inc., 111 Oyster Point Boulevard, South San Francisco, CA 94080, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kombinuotasis vėžio gydymas |
| COMBINATION THERAPY FOR CANCER |
| Payment date | Validity (years) | Amount | |
| 2023-10-09 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-10-28 |